6696261
Last Update Posted: 2024-11-25
Recruiting has not begun
All Genders accepted | 18 Years-65 Years |
342 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome
The goal of this clinical trial is evaluating the efficacy and safety of Lianxiaxiaopi Granules in participant population. The main questions it aims to answer are:
- Based on the Response rate of postprandial distress syndrome participants, evaluate whether the efficacy of Lianxiaxiaopi Granules is superior to placebo.
- Evaluate the efficacy of Lianxiaxiaopi Granules in improving symptom of postprandial distress syndrome.
- Evaluating the safety of Lianxiaxiaopi Granules in postprandial distress syndrome participants.
Eligibility
Relevant conditions:
Postprandial Distress Syndrome
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov